A Seattle doctor lost his legal bid to use psilocybin, the active ingredient in magic mushrooms, to treat terminally ill cancer patients under a Thursday ruling by the country’s largest federal appeals court.
The US Drug Enforcement Administration acted within its authority in barring Sunil Aggarwal from prescribing the psychedelic, a three-judge panel for the US Court of Appeals for the Ninth Circuit said.
The agency provided sufficient reasons for why it would not grant Aggarwal a legal waiver to use the drug under the federal Controlled Substances Act of 1970, which lists psilocybin under the highly restrictive schedule I ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.